A 52-week, open-label, dose-titration safety study of imidapril in the treatment of mild to moderate hypertension

Authors
Category Primary study
JournalCurrent Therapeutic Research - Clinical and Experimental
Year 2001
This article has no abstract
Epistemonikos ID: 738dd7a5d095e21a5ffdbd02455641735dae09e7
First added on: Feb 03, 2025